Clinical trial
SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF)
NCT03842917 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF)
- Lead sponsor
- University Hospital, Tours
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 26, 2019
- Completion date
- June 15, 2022
- Enrollment
- 26 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, patient starting bevacizumab